Kathryn E. Falberg, a director at Trade Desk, Inc. ($TTD), sold shares on the open market twice in the last year, totaling $4.7 million. Her most recent sale occurred on March 5, 2026. These sales rank her 2,042nd among 11,678 individual insiders by sale value, below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | D | Class A Common Stock | 212 | $59.17 | 508.0000 | 497,198,000 | 29.44% | 0.00% |
| March 23, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | D | Class A Common Stock | 1226 | $0.00 | 720.0000 | 497,198,000 | 63.00% | 0.00% |
| March 23, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | D | Class A Common Stock | 212 | $59.17 | 0.0000 | 497,198,000 | 100.00% | 0.00% |
| March 23, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | D | Class A Common Stock | 296 | $59.17 | 212.0000 | 497,198,000 | 58.27% | 0.00% |
| March 5, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | S | Class A Common Stock | 50000 | $30.48 | 1,946.0000 | 497,198,000 | 96.25% | 0.01% |
| March 5, 2026 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | S | Class A Common Stock | 102828 | $30.45 | 1,946.0000 | 497,198,000 | 98.14% | 0.02% |
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | FALBERG KATHRYN E | Director | A | Common Stock | 13300 | $0.00 | 170,706.0000 | 105,841,422 | 8.45% | 0.01% |
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | FALBERG KATHRYN E | Director | A | Stock Option (Rights to Buy) | 38300 | $0.00 | 38,300.0000 | 105,841,422 | 9999.99% | 0.04% |
| May 27, 2025 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 845 | $59.17 | 152,746.0000 | 501,924,000 | 0.56% | 0.00% |
| May 27, 2025 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 845 | $59.17 | 154,774.0000 | 501,924,000 | 0.55% | 0.00% |
| May 27, 2025 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 1183 | $59.17 | 153,929.0000 | 501,924,000 | 0.77% | 0.00% |
| May 27, 2025 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 4901 | $0.00 | 151,901.0000 | 501,924,000 | 3.33% | 0.00% |
| May 21, 2025 | Nuvation Bio Inc. | $NUVB | FALBERG KATHRYN E | Not found | A | Stock Option (Right to Buy) | 292983 | $0.00 | 292,983.0000 | 337,678,855 | 9999.99% | 0.09% |
| April 15, 2025 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 90 | $63.73 | 147,000.0000 | 501,924,000 | 0.06% | 0.00% |
| Sept. 3, 2024 | Nuvation Bio Inc. | $NUVB | FALBERG KATHRYN E | Not found | A | Stock Option (Right to Buy) | 200801 | $0.00 | 200,801.0000 | 0 | 9999.99% | 0.00% |
| Aug. 13, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | S | Class A Common Stock | 150000 | $98.17 | 146,910.0000 | 500,182,000 | 50.52% | 0.03% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | FALBERG KATHRYN E | Director | A | Common Stock | 8400 | $0.00 | 157,406.0000 | 0 | 5.64% | 0.00% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | FALBERG KATHRYN E | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| May 28, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 3155 | $0.00 | 295,764.0000 | 500,182,000 | 1.08% | 0.00% |
| May 28, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 573 | $87.16 | 296,337.0000 | 500,182,000 | 0.19% | 0.00% |
| May 28, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 573 | $87.16 | 296,910.0000 | 500,182,000 | 0.19% | 0.00% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | S | Class A Common Stock | 95 | $82.36 | 292,609.0000 | 500,182,000 | 0.03% | 0.00% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | M | Employee Stock Option Exercise (Right to Buy) | 103030 | $0.00 | 0.0000 | 500,182,000 | 100.00% | 0.02% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | C | Class B Common Stock | 103030 | $0.00 | 0.0000 | 500,182,000 | 100.00% | 0.02% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | C | Class A Common Stock | 103030 | $1.80 | 395,639.0000 | 500,182,000 | 35.21% | 0.02% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | M | Class B Common Stock | 103030 | $0.00 | 103,030.0000 | 500,182,000 | 9999.99% | 0.02% |
| March 8, 2024 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | S | Class A Common Stock | 102935 | $81.90 | 292,704.0000 | 500,182,000 | 26.02% | 0.02% |
| May 25, 2023 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 799 | $62.52 | 292,609.0000 | 499,925,000 | 0.27% | 0.00% |
| May 25, 2023 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 799 | $62.52 | 291,810.0000 | 499,925,000 | 0.27% | 0.00% |
| May 25, 2023 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | A | Class A Common Stock | 4238 | $0.00 | 291,011.0000 | 499,925,000 | 1.48% | 0.00% |
| May 15, 2023 | Nuvation Bio Inc. | $NUVB | FALBERG KATHRYN E | Director | A | Stock Option (Right to Buy) | 366744 | $0.00 | 366,744.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2023 | Trade Desk, Inc. | $TTD | FALBERG KATHRYN E | Director | D | Class A Common Stock | 21 | $59.83 | 286,752.0000 | 499,925,000 | 0.01% | 0.00% |